rs34928857

Variant summary

Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP4_StrongBP6BS1

The NM_033109.5(PNPT1):​c.688G>C​(p.Glu230Gln) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000277 in 1,572,468 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.0016 ( 0 hom., cov: 33)
Exomes 𝑓: 0.00013 ( 0 hom. )

Consequence

PNPT1
NM_033109.5 missense

Scores

6
7
5

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:3B:2

Conservation

PhyloP100: 7.49

Publications

2 publications found
Variant links:
Genes affected
PNPT1 (HGNC:23166): (polyribonucleotide nucleotidyltransferase 1) The protein encoded by this gene belongs to the evolutionary conserved polynucleotide phosphorylase family comprised of phosphate dependent 3'-to-5' exoribonucleases implicated in RNA processing and degradation. This enzyme is predominantly localized in the mitochondrial intermembrane space and is involved in import of RNA to mitochondria. Mutations in this gene have been associated with combined oxidative phosphorylation deficiency-13 and autosomal recessive nonsyndromic deafness-70. Related pseudogenes are found on chromosomes 3 and 7. [provided by RefSeq, Dec 2012]
PNPT1 Gene-Disease associations (from GenCC):
  • combined oxidative phosphorylation defect type 13
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, Ambry Genetics, PanelApp Australia, Labcorp Genetics (formerly Invitae)
  • hearing loss disorder
    Inheritance: AR Classification: DEFINITIVE Submitted by: G2P
  • Leigh syndrome
    Inheritance: AR Classification: MODERATE Submitted by: ClinGen
  • hearing loss, autosomal recessive
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • spinocerebellar ataxia type 25
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
  • autosomal recessive nonsyndromic hearing loss 70
    Inheritance: Unknown, AR Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae), PanelApp Australia

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -9 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.042710304).
BP6
Variant 2-55673071-C-G is Benign according to our data. Variant chr2-55673071-C-G is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 215008.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00162 (246/151902) while in subpopulation AFR AF = 0.00552 (229/41466). AF 95% confidence interval is 0.00494. There are 0 homozygotes in GnomAd4. There are 114 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PNPT1NM_033109.5 linkc.688G>C p.Glu230Gln missense_variant Exon 9 of 28 ENST00000447944.7 NP_149100.2 Q8TCS8
PNPT1XM_005264629.3 linkc.448G>C p.Glu150Gln missense_variant Exon 9 of 28 XP_005264686.1
PNPT1XM_017005172.2 linkc.448G>C p.Glu150Gln missense_variant Exon 8 of 27 XP_016860661.1
PNPT1XM_047446161.1 linkc.688G>C p.Glu230Gln missense_variant Exon 9 of 20 XP_047302117.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PNPT1ENST00000447944.7 linkc.688G>C p.Glu230Gln missense_variant Exon 9 of 28 1 NM_033109.5 ENSP00000400646.2 Q8TCS8
PNPT1ENST00000260604.8 linkn.*243G>C non_coding_transcript_exon_variant Exon 8 of 27 5 ENSP00000260604.4 H7BXF6
PNPT1ENST00000415374.5 linkn.688G>C non_coding_transcript_exon_variant Exon 9 of 29 5 ENSP00000393953.1 Q8TCS8
PNPT1ENST00000260604.8 linkn.*243G>C 3_prime_UTR_variant Exon 8 of 27 5 ENSP00000260604.4 H7BXF6

Frequencies

GnomAD3 genomes
AF:
0.00161
AC:
245
AN:
151784
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00551
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00105
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.000479
GnomAD2 exomes
AF:
0.000447
AC:
93
AN:
207900
AF XY:
0.000351
show subpopulations
Gnomad AFR exome
AF:
0.00552
Gnomad AMR exome
AF:
0.000531
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000100
Gnomad OTH exome
AF:
0.000429
GnomAD4 exome
AF:
0.000133
AC:
189
AN:
1420566
Hom.:
0
Cov.:
31
AF XY:
0.000122
AC XY:
86
AN XY:
706252
show subpopulations
African (AFR)
AF:
0.00489
AC:
150
AN:
30664
American (AMR)
AF:
0.000388
AC:
13
AN:
33490
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
24156
East Asian (EAS)
AF:
0.00
AC:
0
AN:
38354
South Asian (SAS)
AF:
0.0000126
AC:
1
AN:
79314
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
52750
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4528
European-Non Finnish (NFE)
AF:
0.00000182
AC:
2
AN:
1098938
Other (OTH)
AF:
0.000394
AC:
23
AN:
58372
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.478
Heterozygous variant carriers
0
11
22
32
43
54
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00162
AC:
246
AN:
151902
Hom.:
0
Cov.:
33
AF XY:
0.00154
AC XY:
114
AN XY:
74228
show subpopulations
African (AFR)
AF:
0.00552
AC:
229
AN:
41466
American (AMR)
AF:
0.00105
AC:
16
AN:
15224
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3468
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5168
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4784
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10536
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
67948
Other (OTH)
AF:
0.000474
AC:
1
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
12
24
37
49
61
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000157
Hom.:
0
Bravo
AF:
0.00172
ESP6500AA
AF:
0.00545
AC:
24
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.000470
AC:
57
Asia WGS
AF:
0.000289
AC:
1
AN:
3478

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:3Benign:2
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Uncertain:1Benign:1
Jan 27, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Oct 24, 2024
GeneDx
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Observed with a second PNPT1 variant on the opposite allele (in trans) in a patient with arm and leg weakness, developmental delay, scoliosis, epilepsy, and sensory axonal polyneuropathy (PMID: 35303589); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 35303589) -

Combined oxidative phosphorylation defect type 13 Uncertain:1
Mar 25, 2018
Baylor Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was determined to be of uncertain significance according to ACMG Guidelines, 2015 [PMID:25741868]. -

Autosomal recessive nonsyndromic hearing loss 70;C4706283:Combined oxidative phosphorylation defect type 13 Uncertain:1
Oct 31, 2018
Fulgent Genetics, Fulgent Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

PNPT1-related disorder Benign:1
Dec 14, 2020
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.84
BayesDel_addAF
Benign
-0.0021
T
BayesDel_noAF
Pathogenic
0.23
CADD
Pathogenic
28
DANN
Uncertain
1.0
DEOGEN2
Benign
0.37
T
Eigen
Pathogenic
1.1
Eigen_PC
Pathogenic
0.98
FATHMM_MKL
Pathogenic
0.99
D
M_CAP
Benign
0.046
D
MetaRNN
Benign
0.043
T
MetaSVM
Uncertain
0.14
D
MutationAssessor
Pathogenic
4.6
H
PhyloP100
7.5
PrimateAI
Uncertain
0.65
T
PROVEAN
Uncertain
-2.7
D
REVEL
Uncertain
0.41
Sift
Uncertain
0.0030
D
Sift4G
Uncertain
0.0070
D
Polyphen
1.0
D
Vest4
0.94
MVP
0.73
MPC
0.62
ClinPred
0.17
T
GERP RS
5.7
Varity_R
0.93
gMVP
0.87
Mutation Taster
=35/65
disease causing

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.030
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs34928857; hg19: chr2-55900206; API